Abstract
Introduction
Blood vessels have evolved to carry oxygen, nutrients and signaling molecules to distant organs in vertebrates higher than amphibians. The establishment of the primitive vascular plexus from angioblasts [1] [3] ).
Endothelial phenotypic changes in diverse settings of angiogenesis are under intense scientific scrutiny in search for novel biomarkers with potential for therapy [3] [4] [5] . [6, 7] , extremely few TEC [8] and virtually no fenestrae. In select continuous endothelia (e.g. lung, tongue) caveolae can be provided with a stomatal diaphragm (SD) . In addition to relatively fewer caveolae, the fenestrated endothelium (Fig. 1B) features specialized microdomains such as fenestrae, TEC and endothelial pockets [9] [10] [11] [12] [13] [14] . This [12, 14] . 
An interesting and less explored observation is the expression by endothelial cells of specific subcellular structures such as caveolae and their stomatal diaphragms, fenestrae, transendothelial channels (TEC) and vesiculo-vacuolar organelles (VVOs). This review will discuss the knowledge on the structure function and regulation of these structures in normal endothelia as well as in angiogenesis.

Endothelial phenotypesmorphology
Vascular endothelium is a highly differentiated cellular monolayer with the organization of a simple squamous epithelium. It lines the entire cardiovascular system and thus constitutes a quasi-ubiquitous presence in organs and tissues throughout the body. From a morphological point of view, depending on their content of specific structures, endothelia have been classically defined into three main structural types: the continuous, fenestrated and discontinuous endothelium. The continuous endothelium (Fig. 1A) occurs in all large vessels (both arteries and veins) and microvessels of the body wall (skin, skeletal muscles) as well as those of the visceral muscles (myocardium included) and the lung. As reflected by its name, its main characteristic is the formation of a continuous, uninterrupted barrier between the blood and tissues. In a quiescent state it features a large population of caveolae or plasmalemmal vesicles
Structure of endothelial stomatal and fenestral diaphragms in normal endothelium
Caveolae and their stomatal diaphragms
Caveolae (or plasmalemmal vesicles) were first described in the endothelium of continuous type [6] but they occur in all types of endothelia as well as most mammalian cell types (for a review see ref. [16] [17, 18] and Fig. 2A, B) . By [20, 21] , which implies its protein nature (reviewed in ref. [16] ). [22] . The octagonal symmetry has been clearly established by deep-etch of rapidly frozen specimens [17] and high resolution scanning electron microscopy [23] .
Endothelial fenestrae
The fenestrae are provided with a Fenestral Diaphragm (FD) [9] [17] (Fig. 2C) [17] . It was readily apparent that the caveolar diaphragms resembled those of the TEC both featuring a central particle [17] (Fig. 7A) . Close examination also reveals hints of the same radial fibrils pattern as for fenestral diaphragms (Fig. 7B) 
Transendothelial channels (TEC)
TEC are patent pores spanning the endothelial cell body from lumen to ablumen (Fig. 7A, [7, 8, 30] . In the fenestrated endothelia, TEC occur in the attenuated part of the endothelial cell and are provided with two SDs (one luminal and one abluminal) [11, 12, 30, 31] 
Endothelial pockets
These are infrequent structures that by electron microscopy resemble a pocket or a large vacuole formed by cellular processes that contain fenestrae with the usual structure. The information on these is scarce and, so far, they seem to occur in very low numbers only in the fenestrated endothelia [13] . 
Structures present in the endothelium in neovascularization
Vasculogenesis and angiogenesis in the embryo
Arteriogenesis
Arteriogenesis is defined as development and growth of collateral arteries [2, 50] . There is little information regarding the ultrastructure of endothelium in this process. From the few ultrastructural studies done, there is no evidence of the occurrence of the endothelial specific structures on the endothelium during collateral growth [51, 52] . [53] the continuous endothelium of muscle capillaries becomes fenestrated, observation confirmed by different groups [54] [55] [56] .
Angiogenesis in the adult
Angiogenesis in the adult occurs in the ovaries, uterus and during wound healing. The vasculature of the ovaries is fenestrated. One of the earliest observations on the induction of fenestrae is that during wound healing in regenerating muscle
Pathologic angiogenesis
Electron microscopy studies documented pathological conditions where the continuous endothelium becomes fenestrated in cases such as the aberrant capillary loops that appear in the neovasculature of psoriatic lesions in skin [57] in the chronic inflammation of gingiva [58] during lung fibrosis [59] , chronic allergic encephalomyelitis [60] , delayed radiation necrosis [61] , experimental lead encephalopathy [62] , diabetic retinopathy [63] , rheumatoid arthritis [64, 65] and especially the neovasculature of many solid tumours (reviewed in ref. [31] ) [35, 62, [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] .
Components of the stomatal and fenestral diaphragm Plasmalemma vesicle associated protein (gp68, PV-1, PV1)
Recently, the stomatal and fenestral diaphragms were shown to share at least one biochemical marker, namely PV1 [77, 78] . PV1 protein was discovered as the antigen of a novel endothelial antibody (21D5 mAb) [79] , which co-localized strictly on endothelial caveolae from rat lung immunoisolated on anti-caveolin 1 antibodies [80] . (8 aa) and contains a putative caveolin 1 binding domain [16] . The other one at the extreme N-terminus (7 aa 
Gene features and expression of mRNA
Localization
At protein level, PV1 was confirmed to be present in the organs where the mRNA is present [16, 78] . PV1 seems to be endothelium-specific, [78] [78] and our unpublished data).
By immunocytochemistry (Fig. 3) , PV1 was found to be specifically associated with the SDs of caveolae and TEC and the fenestral diaphragms, at both fronts of endothelial cells [77, 78] There is some controversy as to the endothelial specificity of PV1 protein [81, [83] [84] [85] [79, [86] [87] [88] [89] [90] [91] . Moreover during the last few (Fig. 4A-E) ; (iv) PV1 knockdown by siRNA prevents the formation of both fenestral and SDs (Fig. 4F) [92] .
Fig. 3 Immunolocalization of PV1 by immunodifussion to stomatal diaphragms of caveolae in lung (A-B, E), stomatal diaphragms of TEC (D-E) and fenestral diaphragms (C-D, F), as detected with anti-PV1 antibodies directed against its C-terminus. (A-B) lung, C-E) kidney, (F) intestine. The label was found specifically associated with the stomatals and fenestral diaphragms at both fronts of the cell. No label was found on the plasmalemma proper, clathrin-coated pits and vesicles, intercellular junctions as well as non
Other components
The chemical components of the SDs of caveolae and TEC and those of the fenestral diaphragms have been investigated with 'general', nonspecific probes such as lectins [94] [95] [96] [97] and cationic molecules [21, [98] [99] [100] [101] . It has been shown that SDs and fenestral diaphragms behave differently: the former bind lectins avidly and lack anionic sites, while the latter do not [94] or poorly [95] bind lectins and have multiple anionic sites conferred by HSPGs [20] . The presence of the lectin binding sites on SDs and fenestral diaphragms, combined with their protein nature (sensitive to protease degradation) [20] suggest the presence of glycoproteins in their structure. The HSPGs are present only on the luminal side of fenestral diaphragms Fig. 4 PMA induces TEC (B, I), fenestrae (A, B, G, I [99] , which correlates with the data obtained by fixation in the presence of fluorocarbons [29] .
Working model of PV1 integration in the structure of the diaphragms
Based on the data in the literature a working hypothesis has been formulated (depicted in Fig. 7D ) in which both SDs and fenestral diaphragms consist of a common framework of radial fibrils inserted in the rim of a pore (i.e. caveolar or TEC introit or fenestral pore) and interweave in the center of the diaphragm (Fig. 7D) Fig. 7C 
. The fibrils would consist of PV1 dimers whose C termini would form the central density of the diaphragm [44]. The dimers could be 'kept afloat' by the heavy (~15% of the PV1 mass) glycosylation that occurs nearby the membrane (see
and ref. [44]). The diaphragm structure could be stabilized via interactions between PV1 C termini themselves or with another putative diaphragm stabilizing extracellular protein. Alternatively or in addition, the diaphragm could be stabilized by the existence of a rigid structure on the cytoplasmic face of the rim presumably connected to the cytoskeleton. This latter assumption seems to be sustained by data obtained with affinity chromatography and yeast two-hybrid screening using the intracellular domain of PV1, by which assays cytoskeletal linker molecules interact with PV1 (R. Stan, unpublished observations). The HSPGs could interfere with the binding of the lectins in fenestrae, to explain the lack of fenestral
Fig. 5 Transfection of PV1 in HUVEC leads to de novo formation of stomatal diaphragms of caveolae. No TEC or fenestrae are formed. (A) control HUVEC (B-C) HUVEC transfected with PV1-HA and stained with anti-HA gold (B).
Fig. 6 PV1 (red) is expressed in tumor vessels where it colocalizes with CD31 (green).
Fig. 7 Proposed model for PV1 integration in the structure of the diaphragms. (A) Perpendicular sections of a caveola provided with stomatal diaphragm (left), TEC (middle) and fenestra (right). (B) En face views of stomatal diaphragms (left) and fenestral diaphragms (right), as shown by deep-etch rapid-freeze techniques, demonstrating the fibrils in the fenestral diaphragms and the hints of fibrils in their stomatal diaphragms counterparts. Reprinted from Bearer and Orci, JCB, 1985, with permission. (C) Schematic of the membrane insertion and features of the PV1 monomer. (D) Model of PV1 integration in the endothelial diaphragms: PV1 dimers participate in the formation of the fibrils inserted in the rim (via PV1 N-terminus) and interweaving in the central mesh (via PV1 C terminus). The glycan antennae (accounting for ~15% of PV1 mass) are situated near the membrane, which would keep the protein 'afloat' by preventing collapse on the plasma membrane.
binding [94] or poor binding [102] [77] , which explains the absence of binding of cationized ferritin [20, 21] 103] . [105, 106] 
Or (ii) a different biogenetic pathway between fenestrae and caveolae with the HSPGs as a filtration residue or (iii) a different biogenetic pathway between fenestrae and caveolae by which HSPGs are specifically targeted to the fenestral pore. The first hypothesis was proposed in an attempt to provide an explanation for the morphological similarity between the SDs and fenestral diaphragms and their apparent chemical differences (i.e. lectin binding and anionic sites). And this within the following paradigm of fenestrae biogenesis: TEC would arise by fusion of caveolae/plasmalemmal vesicles from both fronts of endothelial cells and fenestrae would be formed through the collapse of TEC to minimal path length [31]. As fenestrae were considered relatively stable structures spatially and temporally, the HSPGs could be added to their structure as a filtration residue, in view of their function as a permeability site [104]. The endothelial cells are know to shed HSPGs [105] although the extremely low levels of GAG chains or HSPGs circulating in blood plasma
Regulation of endothelial specific structures PV1 and diaphragms are lost upon endothelial cell dedifferentiation in cell culture
The phenotypic drift suffered by primary endothelial cells in culture is well established [110, 111] . This is shown by the differences in the surface density of endothelial cell specific structures as well as expression of gene products. Endothelial cells from bovine adrenals (BAEC) lose their fenestrae and TEC once in culture [112, 113] . Likewise, the number of caveolae and their SDs is drastically reduced in lung microvascular endothelial cells from both human and rat (HLMVEC and RLMVEC, respectively) , in which case PV1 expression is also lost [92] . Also VVOs are lost in culture and need special treatment to be reinduced [114] .
The diaphragms are inducible structures
Matrix components
The first demonstration of fenestrae and TEC induction in vitro was done by Milici et al. [14] [115] .
Phorbol esters
In a series of papers during the 1980s, Lombardi et al. [113, 116, 117] [113, 116, 117] where Rac1 is known to have a major role (for review see ref. [127] and references therein). In this system, PMA/DAG could activate Rac1 via chimaerin [118] [128] .
Another paper [129] [133] [134] [135] [136] .
Recently, Madden et al., showed by SAGE that PV1, the protein component of the diaphragms, was one of the most upregulated endothelial cell genes in glioblastoma vessels and that PV1 mRNA was induced by seeding human dermal endothelial cells onto Matrigel [138] . Next, it was shown that PV1 is upregulated by VEGF in HUVEC in culture via its VEGFR2 and that PV1 was expressed on endothelial cells from a multitude of tumours [139] . These findings were subsequently confirmed by data showing that PV1 is upregulated in endothelial cells by tumour cell conditioned medium, VEGF as well as HGF [140] . Moreover, PV1 was shown to facilitate endothelial cell migration, due to which it was proposed as a novel anti-angiogenic target [140] . However, there are other opinions on this [141] Moreover, PV1 was also identified [142] as the antigen of PAL-E, a widely used human endothelial specific monoclonal antibody [143] shown to be expressed on endothelium in wound healing [144, 145] , tumours [146] [147] [148] such as angiosarcoma [149, 150] , Kaposi sarcoma [150] [151] [152] [153] , Wilm's tumour [154] , brain tumours [155, 156] , colorectal adenocarcinoma [144] , melanoma [157, 158] , hepatocellular carcinoma [159] , breast cancer [160] and hemangiomas [161] . The presence of PV1 in tumour endothelium is illustrated in Figure 6 .
The induction of fenestrae by VEGF is not a matter of general agreement, however. The neovasculature of some VEGF-producing tumours was found devoid of fenestrae while they are present in other tumours [34, 35, 162] . Moreover, the numbers of fenestrated vessels in transgenic mice overexpressing VEGF in skin is not increased as compared to controls as reported in a review [34] , citing unpublished observations. Also, the injection of VEGF in monkey eyes promotes formation of neovessels that are not fenestrated. The increased leakiness of these latter vessels was suggested to occur by increased vesi cular transport [163] .
A model for VVO induction in cells in culture was also reported [114] 
Other angiogenic factors that induce diaphragms
Leptin, a hormone with angiogenic activity secreted by the adipocytes, also causes fenestration of endothelia [164] in situ. In normal ovaries, human choriogonadotropin (hCG) was linked to the formation of fenestrae whereas interleukin 8 does not seem to have this function [165] . [16, 38, 166, 167] 
Function of endothelial diaphragms in normal vessels and angiogenesis
